Corindus Vascular Robotics Inc (CVRS) Director Louis A. Cannon Acquires 10,000 Shares

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon bought 10,000 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was bought at an average cost of $1.80 per share, with a total value of $18,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CVRS opened at $1.78 on Thursday. Corindus Vascular Robotics Inc has a 52-week low of $0.70 and a 52-week high of $2.54.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). The company had revenue of $4.67 million during the quarter, compared to analyst estimates of $5.60 million.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter worth $36,000. HRT Financial LLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter worth $44,000. Virtu Financial LLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter worth $64,000. Citadel Advisors LLC grew its holdings in shares of Corindus Vascular Robotics by 205.4% during the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after purchasing an additional 77,829 shares during the period. Finally, Barclays PLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter worth $325,000.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Fairfield Current and is owned by of Fairfield Current. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.fairfieldcurrent.com/news/2019/03/28/corindus-vascular-robotics-inc-cvrs-director-louis-a-cannon-acquires-10000-shares.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

See Also: Limitations of the P/E Growth ratio

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.